These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 7432364)

  • 1. Induction of trifluorothymidine-resistant mutants by metal ions in L5178Y/TK+/- cells.
    Amacher DE; Paillet SC
    Mutat Res; 1980 Jul; 78(3):279-88. PubMed ID: 7432364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutagenesis at the ouabain-resistance locus of 3.7.2C L5178Y cells by chromosomal mutagens.
    Amacher DE; Dunn EM
    Environ Mutagen; 1985; 7(4):523-33. PubMed ID: 2996875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of mammalian cell mutagens in urine from carcinogen-dosed mice.
    Amacher DE; Turner GN; Ellis JH
    Mutat Res; 1981 Sep; 90(1):79-90. PubMed ID: 7029272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The critical influence of temperature upon trifluorothymidine resistance in mouse lymphoma L5178Y/TK 3.7.2C cells.
    Amacher DE; Turner GN
    Mutat Res; 1989 Dec; 224(4):415-26. PubMed ID: 2479834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Point mutations at the thymidine kinase locus in L5178Y mouse lymphoma cells. I. Application to genetic toxicological testing.
    Amacher DE; Paillet S; Ray VA
    Mutat Res; 1979 Dec; 64(6):391-406. PubMed ID: 392313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The mutagenicity of sodium fluoride to L5178Y [wild-type and TK+/- (3.7.2c)] mouse lymphoma cells.
    Cole J; Muriel WJ; Bridges BA
    Mutagenesis; 1986 Mar; 1(2):157-67. PubMed ID: 3333272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The mutagenicity of 5-azacytidine and other inhibitors of replicative DNA synthesis in the L5178Y mouse lymphoma cell.
    Amacher DE; Turner GN
    Mutat Res; 1987 Jan; 176(1):123-31. PubMed ID: 2432424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ascorbate is detectably mutagenic in the L5178Y TK+/- cell mutation assay.
    Amacher DE; Paillet SC
    Cancer Lett; 1981 Nov; 14(2):151-8. PubMed ID: 7317878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mutagenicity of 2-amino-N6-hydroxyadenine to L5178Y tk +/- 3.7.2C mouse lymphoma cells: measurement of mutations to ouabain, 6-thioguanine and trifluorothymidine resistance, and the induction of micronuclei.
    Cole J; Richmond FN; Bridges BA
    Mutat Res; 1991 Aug; 253(1):55-62. PubMed ID: 1908053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of viral transformation for evaluation of the carcinogenic or mutagenic potential of inorganic metal salts.
    Casto BC; Meyers J; DiPaolo JA
    Cancer Res; 1979 Jan; 39(1):193-8. PubMed ID: 570089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interlaboratory validation of a new assay for DNA-protein crosslinks.
    Costa M; Zhitkovich A; Gargas M; Paustenbach D; Finley B; Kuykendall J; Billings R; Carlson TJ; Wetterhahn K; Xu J; Patierno S; Bogdanffy M
    Mutat Res; 1996 Jul; 369(1-2):13-21. PubMed ID: 8700178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation and characterization of the L5178Y/TK+/- mouse lymphoma mutagen assay system.
    Clive D; Johnson KO; Spector JF; Batson AG; Brown MM
    Mutat Res; 1979 Jan; 59(1):61-108. PubMed ID: 372791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of trifluorothymidine-resistant (TFTr) mutants of L5178Y/TK+/- mouse lymphoma cells.
    Moore MM; Clive D; Hozier JC; Howard BE; Batson AG; Turner NT; Sawyer J
    Mutat Res; 1985 Aug; 151(1):161-74. PubMed ID: 3927157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hamster hepatocyte-mediated activation of procarcinogens to mutagens in the L5178Y/TK mutation assay.
    Amacher DE; Paillet SC
    Mutat Res; 1982 Dec; 106(2):305-16. PubMed ID: 7155171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergism of mutant frequencies in the mouse lymphoma cell mutagenicity assay by binary mixtures of methyl methanesulfonate and ethyl methanesulfonate.
    Tarlo KS; Boehnke M; Chin B
    Mutat Res; 1988 Oct; 206(2):239-46. PubMed ID: 3173391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutagenicity and clastogenicity of teniposide (VM-26) in L5178Y/TK +/- -3.7.2C mouse lymphoma cells.
    DeMarini DM; Brock KH; Doerr CL; Moore MM
    Mutat Res; 1987 Mar; 187(3):141-9. PubMed ID: 3821767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Point mutations at the thymidine kinase locus in L5178Y mouse lymphoma cells. II. Test validation and interpretation.
    Amacher DE; Paillet SC; Turner GN; Ray VA; Salsburg DS
    Mutat Res; 1980 Aug; 72(3):447-74. PubMed ID: 7453708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific gene mutations in L5178Y cells in culture.
    Clive D; McCuen R; Spector JF; Piper C; Mavournin KH
    Mutat Res; 1983 Jun; 115(2):225-51. PubMed ID: 6855786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A method to distinguish between the de novo induction of thymidine kinase mutants and the selection of pre-existing thymidine kinase mutants in the mouse lymphoma assay.
    Wang J; Heflich RH; Moore MM
    Mutat Res; 2007 Jan; 626(1-2):185-90. PubMed ID: 17055776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stability of tk-/- mutants of L5178Y mouse lymphoma cells in Fischer's medium.
    Clive D; Krehl R
    Mutat Res; 1991 Aug; 260(4):409-13. PubMed ID: 1908056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.